Pharmafile Logo

Ig-Innovations

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ not the name we give the company. Born-out of the acquisition of the diagnostics division of MicroPharm, Ig has captured the skills and expertise developed during the research and development of sheep derived polyclonal antibodies for human therapy (now FDA & MHRA licensed products), diagnostics and research.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Gernos, Maesllyn, Llandysul, SA44 5LP
+44 (0)1239 858972

 Latest Content from PMHub 

We Can Shorten the Journey

Press Releases | February 1, 2024 | Medscape Education

During the shortest month of the year, Medscape Education is making a renewed commitment to use clinician education to help shorten the diagnostic and treatment journey for the millions of...

OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

Press Releases | January 31, 2024 | OPEN Health

OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

Clinical trials explained: Why imagery matters…

Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Clinical trials explained: Why health literacy matters…

Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies.

Inside Mednet’s Writing Academy: How do you mentor excellence?

White Papers and Resources | January 24, 2024 | Mednet

Medical Writer, Tayyibah Ali looks at how we mentor excellence within our team

We are EatMoreFruit

Videos and Podcasts | January 23, 2024 | EatMoreFruit

Welcome to EatMoreFruit - We are a London-based top 10 independent healthcare communications agency. PR, digital, creative & commercial strategies for innovators in health, pharma and wellbeing.

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

Press Releases | January 22, 2024 | OPEN Health

OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer